“…Early recognition of APS is crucial, while aggressive management can result in a favorable outcome (2)(3)(4)(5). The recognized renal manifestations of this syndrome defined as APS nephropathy, are the renal artery thrombosis/stenosis, renal vein thrombosis, renal infarction, end-stage renal disease, increased allograft vascular thrombosis, some types of glomerular disease, hypertension and thrombotic microangiopathy (TMA) (1,2,(10)(11)(12). TMA is characterized by acute thrombotic lesions in glomeruli and/ or arterioles and chronic vascular lesions such as fibrous intimal hyperplasia of arterioles and interlobular arteries, organized thrombi with or without recanalization, and fibrous arterial and arteriolar occlusions or focal cortical atrophy (3)(4)(5)(6)(7)(8)(9).…”